Boule Diagnostics AB operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boule Diagnostics AB with three other
companies in this sector in SWEDEN :
Cellavision AB
(2020
sales of 471.44 million Swedish Kronor [US$56.13 million]
of which 100%
was Automatic Microscopy),
C Rad AB
(221.63 million Swedish Kronor [US$26.38 million]
of which 100%
was Positioning external sales), and
Cellink AB
(312.01 million Swedish Kronor [US$37.14 million]
of which 63%
was Laboratory Solutions).
Sales Analysis.
Boule Diagnostics AB reported sales of SEK 400.46 million (US$47.67 million)
for the
year ending
December of 2020.
This
represents
a
decrease of 19.7%
versus 2019, when the company's sales were SEK 498.92 million.
Contributing to the drop in overall sales was the 30.1% decline
in Instruments, from SEK 172.70 million to SEK 120.65 million.
There were also decreases in sales in
Own Consumables (down 16.5% to SEK 179.70 million)
and
Oem and Cds Consumables (down 4.4% to SEK 62.49 million)
.